Insulin-Like Growth Factor-1 Regulates Neurite Outgrowth and Neuronal Migration From Organotypic Cultured Dorsal Root Ganglion

REFERENCES

• Akahori, Y., & Horie, H. (1997). IGF-I enhances neurite regeneration but is not required for its survival in adult DRG explant. Neuroreport, 8(9–10), 2265–2269.
   PubMedGoogle Scholar
• Baker, A. M., Batchelor, D. C., Thomas, G. B., Wen, J. Y., Rafiee, M., Lin, H., (2005). Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat. Neuropeptides, 39(2), 81–87.
   PubMed Web of Science ®Google Scholar
• Batchelor, D. C., Lin, H., Wen, J. Y., Keven, C., Van Zijl, P. L., Breier, B. H., (2003). Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats. Analytical Biochemistry, 323(2), 156–163.
   PubMed Web of Science ®Google Scholar
• Bilak, M. M., & Kuncl, R. W. (2001). Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons. Neuroreport, 12(11), 2531–2535.
   PubMedGoogle Scholar
• Bomze, H. M., Bulsara, K. R., Iskandar, B. J., Caroni, P., & Skene, J. H. (2001). Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons. Nature Neuroscience, 4(1), 38–43.
   PubMed Web of Science ®Google Scholar
• Cheng, H. L., Russell, J. W., & Feldman, E. L. (1999). IGF-I promotes peripheral nervous system myelination. Annals of the New York Academy of Sciences, 883, 124–130
   PubMed Web of Science ®Google Scholar
• Craner, M. J., Klein, J. P., Black, J. A., & Waxman, S. G. (2002). Preferential expression of IGF-I in small DRG neurons and down-regulation following injury. Neuroreport, 13(13), 1649–1652.
   PubMedGoogle Scholar
• Escartin, C., Boyer, F., Bemelmans, A. P., Hantraye, P., & Brouillet, E. (2007). IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. Neuroscience Letter, 425(3), 167–172.
   PubMedGoogle Scholar
• Gonzalez de la Vega, A., Buño, W., Pons, S., Garcia-Calderat, M. S., Garcia-Galloway, E., & Torres-Aleman, I. (2001). Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathway. Neuroreport, 12(6), 1293–1296.
   PubMedGoogle Scholar
• Guan, J., Bennet, L., Gluckman, P. D., & Gunn, A. J. (2005). Treatment in animal models. Endocrine Development, 9, 31–43.
   PubMedGoogle Scholar
• Guan, J., Bennet, T. L., George, S., Waldvogel, H. J., Faull, R. L., Gluckman, P. D., (2000). Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep. Neuroscience, 95(3), 831–839.
   PubMedGoogle Scholar
• Guan, J. (2008). Insulin-like growth factor-1 and its derivatives: Potential pharmaceutical application for ischemic brain injury. Recent Patents CNS Drug Discovery, 3(2), 112–127.
   PubMedGoogle Scholar
• Guan, J., Thomas, G. B., Lin, H., Mathai, S., Bachelor, D.C., George, S., (2004). Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats. Neuropharmacology, 47(6), 892–903.
   PubMedGoogle Scholar
• Jones, D. M., Tucker, B. A., Rahimtula, M., & Mearow, K. M. (2003). The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: Convergence on the PI 3-kinase signaling pathway. Journal of Neurochemistry, 86(5), 1116–1128.
   PubMedGoogle Scholar
• Leinninger, G. M., Backus, C., Uhler, M. D., Lentz, S. I., & Feldman, E. L. (2004). Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB Journal, 18(13), 1544–1546.
   PubMedGoogle Scholar
• Liang, G., Cline, G. W., & Macica, C. M. (2007). IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination. Glia, 55(6), 632–641.
   PubMed Web of Science ®Google Scholar
• Liu, H., Liu, Z., Yang, X., Huang, F., Ma, C., & Li, Z. (2008). Neurotoxicity caused by didanosine on cultured dorsal root ganglion neurons. Cell Biology and Toxicology, 24(1), 113–121.
   PubMedGoogle Scholar
• Marshall, J., Dolan, B. M., Garcia, E. P., Sathe, S., Tang, X., Mao, Z., (2003). Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron, 39(4), 625–639.
   PubMedGoogle Scholar
• McCusker, R. H., McCrea, K., Zunich, S., Dantzer, R., Broussard, S. R., Johnson, R. W., (2006). Insulin-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocortical neurons. Journal of Neuroimmunology, 179(1–2), 186–190.
   PubMedGoogle Scholar
• Russell, J. W., Cheng, H. L., & Golovoy, D. (2000). Insulin-like growth factor-I promotes myelination of peripheral sensory axons. Journal of Neuropathology and Experimental Neurology, 59(7), 575–584.
   PubMedGoogle Scholar
• Russo, V. C., Kobayashi, K., Najdovska, S., Baker, N. L., & Werther, G. A. (2004). Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: A role for the insulin-like growth factor system. Brain Research, 1009(1–2), 40–53.
   PubMed Web of Science ®Google Scholar
• Sizonenko, S. V., Sirimanne, E. S., Williams, C. E., & Gluckman, P. D. (2001). Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury. Brain Research, 922(1), 42–50.
   PubMedGoogle Scholar
• Svensson, J., Diez, M., Engel, J., Wass, C., Tivesten, A., Jansson, J. O., (2006). Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. Journal of Endocrinology, 189(3), 617–627.
   PubMedGoogle Scholar
• Vincent, A. M., Mobley, B. C., Hiller, A., & Feldman, E. L. (2004). IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiology of Disease, 16(2), 407–416.
   PubMedGoogle Scholar
• Wood, T. L., Loladze, V., Altieri, S., Gangoli, N., Levison, S. W., Brywe, K. G., (2007). Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Developmental Neuroscience, 29(4–5), 302–310.
   Google Scholar
• Xing, C., Peng, Y., Chang, R., Yin, Y., & Xie, Z. (2005). Effects of insulin-like growth factor-1 on okadaic acid-induced apoptosis in SH-SY5Y cells. Cell Biology International, 29(9), 803–808.
   PubMedGoogle Scholar
• Zhao, X., Liu, S. J., Zhang, J., Strong, R., Aronowski, J., & Grotta, J. C. (2005). Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Stroke, 36(1), 129–134.
   PubMedGoogle Scholar
• Zheng, W. H., & Quirion, R. (2006). Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neuroscience, 7, 51.
   PubMed Web of Science ®Google Scholar
• Zhong, J., Deng, J., Huang, S., Yang, X., & Lee, W. H. (2004). High K+ and IGF-1 protect cerebellar granule neurons via distinct signaling pathways. Journal of Neuroscience Research, 75(6), 794–806.
   PubMed Web of Science ®Google Scholar
• Zhong, J., Deng, J., Phan, J., Dlouhy, S., Wu, H., Yao, W., (2005). Insulin-like growth factor-I protects granule neurons from apoptosis and improves ataxia in weaver mice. Journal of Neuroscience Research, 80(4), 481–490.
   PubMed Web of Science ®Google Scholar